Term
For dually innervated organs, which usually dominates (SANS or PANS)? What is the exception to this? |
|
Definition
PANS
Exception: Blood vessels only have SANS innervation |
|
|
Term
Which body part only has SANS innervation? |
|
Definition
|
|
Term
|
Definition
this is the neurotransmitter Acetylcholine (ACh) |
|
|
Term
|
Definition
This is the neurotransmitter Epinephrine |
|
|
Term
|
Definition
This is the neurotransmitter Norepinephrine |
|
|
Term
Which part(s) of the ANS does Acetycholine innervate? |
|
Definition
|
|
Term
Which part(s) of the ANS does Norepinephrine innervate? |
|
Definition
|
|
Term
Which part(s) of the ANS does Epinephrine innervate? |
|
Definition
|
|
Term
Compare SANS ganglia to PANS ganglia in terms of location from the spinal cord, and the lengths of their pre-ganglionic and post-ganglionic fibers |
|
Definition
SANS ganglia
-lie close to the spinal cord;
-preganglionic are short. Post are long
PANS ganglia
-are located near, or in, the organ innervated.
-preganglion are long. Post are short |
|
|
Term
What is the neurotransmitter at all cholinergic receptors? |
|
Definition
|
|
Term
What are the 2 types of cholinergic receptors? |
|
Definition
Nicotinic (N) and Muscarinic (M) receptors |
|
|
Term
Which part of the ANS and which general body areas are the Muscarinic receptors located? |
|
Definition
These are present on all tissues or organs innervated by PANS & also on thermoregulatory sweat glands that are innervated by SANS! |
|
|
Term
Which part of the ANS are Nicotinic receptors located, and which general parts of the body can they be found? |
|
Definition
Nicotinic receptors are located in all ANS ganglia (both PANS & SANS) and also at skeletal muscle endplates innervated by somatic motor nerves. |
|
|
Term
What is the predominant neurotransmitter released at the SANS, and which type of receptors does it activate? |
|
Definition
Norepinephrine (NE) is the predominant neurotransmitter released at SANS nerve endings and activates adrenergic receptors (also called adrenoreceptors) of two main types: alpha receptors & beta receptors |
|
|
Term
Which particular nervous system, and which general partso f the body, are alpha and beta receptors found in/on? |
|
Definition
Alpha or beta adrenoreceptors are present on most organs innervated by the SANS & they are also present on some tissues (especially vascular smooth muscle) |
|
|
Term
What effect do alpha and beta receptors have on vascular smooth mucle |
|
Definition
No effect, since no innervation occurs in the vascular smooth muscle. |
|
|
Term
Where is Epinephrine released from, and which receptors does it act on? |
|
Definition
Epinephrine (E) is released into the blood from the adrenal medulla and activates ALL adrenoceptors |
|
|
Term
Which parts of the body are Dopamine (DA) located? |
|
Definition
Dopamine (DA) is a neurotransmitter at vascular smooth muscle in kidney and the enteric circulation |
|
|
Term
List the 2 major adrenergic receptors, and their their subtypes. |
|
Definition
Alpha receptors: subtypes include alpha-1 and alpha-2
Beta receptors: subtypes include beta-1 and beta-2 |
|
|
Term
List the 2 major cholinergic receptors and their subtypes |
|
Definition
Nicotinic receptors:
- subtypes include Neuronal receptors (NN) and Neuromuscular receptors (NM)
Muscarinic receptors:
- subtypes include M1, M2, and M3 receptors
|
|
|
Term
What does NN stand for, and what is it? |
|
Definition
Neruronal Nicotinic
It is a type of nicotinic receptor under the class of cholinergic receptors which are part of the PANS |
|
|
Term
What does NM stand for, and what is it? |
|
Definition
Neuromuscular Nicotinic receptor.
This is a Nicotinic receptor, which is a type of cholinergic receptor which is part of the PANS |
|
|
Term
Which part of the nervous system uses adrenergic receptors?
Which types of neurotransmitters do adrenergic receptor utilize? |
|
Definition
Adrenergic receptors are part of the SANS.
They utilize norepinephrine, epinephrine and dopamine |
|
|
Term
Which type of receoptor is used in both the SANS and PANS? Which gangiolial parts are they located in (preganglia/postganglia)? What is their location/function in the somatic nervous system? |
|
Definition
Nicotinic receptors.
These are located in the preganglia receptors of the ganglia in the SANS and PANS
They are also located at the end of the motor neurons of the somatic nervous system, where they innervate skeletal muscles. |
|
|
Term
What is the Enteric Nervous System, which part(s) of the body does it affect, and what are it's functions? |
|
Definition
The enteric nervous system (ENS) directly controls activities in the gastrointestinal system. It is capable of autonomous functions such as the coordination of GI reflexes (“the second brain”), although it does receive innervation from the ANS and is often considered a part of it.
Activities include control of gastrointestinal peristalsis & secretion of hormones and enzymes. |
|
|
Term
Which neurotransmitters and regulatory substances does the Enteric Nervous System utilize? (8 answers) |
|
Definition
The ENS uses the same neurotransmitters ACh and NE.
Cholecystokinin (CCK) – possible co-transmitter in ENS
Enkephalins – small peptides found in ENS neurons (& elsewhere) - inhibit peristalsis & increase GI secretions
Related peptides (endorphins) mediate pain responses in the spinal cord
Nitric oxide (NO) – ENS co-transmitter, vascular relaxation
Serotonin* (5HT) – transmitter in the ENS
Substance P – sensory neurotransmitter in ENS |
|
|
Term
What are the two types of ganglia that ENS neurons are located within? Where are these ganglia located? |
|
Definition
ENS neurons are collected into two types of ganglia known as myenteric (Auerbach’s) and submucosal (Meissner’s) plexuses.
•Submucosal (Meissner’s) plexuses are in the outer layer of the GI tract (muscularisexterna)
•Myenteric (Auerbach’s) plexuses are located between the inner and outer layers of the muscularisexterna. |
|
|
Term
True or False
AChE inhibitors do NOT have actions at receptors that are not innervated! |
|
Definition
|
|
Term
What are the 4 classes of drugs that act on the cholinergic system of receptors |
|
Definition
1.Direct activators (agonists) of M and/or N receptors
2. Inhibitors of acetylcholinesterase, the enzyme that
inactivates ACh – these agents increase ACh
actions at both M & N receptors – non-selective!
3. Blockers (antagonists) of M receptors
4. Blockers (antagonists) of N receptors |
|
|
Term
When a drug can work on more than one receptor and tissue, how do you produce a highly selective action? |
|
Definition
Administer the drug locally Choose a drug that has a higher affinity for one receptor than the other. |
|
|
Term
What happens if a drug is able to cross the blood brain barrier? |
|
Definition
it will impact the entire ANS, both the SANS and PANS |
|
|
Term
What are the effects of ADVERSE EFFECTS of CHOLINOCEPTOR ACTIVATING DRUGS? |
|
Definition
DUMBBELSS
diarrhea, urination, miosis, bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating |
|
|
Term
What is the condition of having too much ACh working in the heart, lungs, and CNS? |
|
Definition
This is a form of organophosphate poisoning |
|
|
Term
What happens when Nicotinic receptors are activated in the ANS ganglia? What type of Nicotinic receptors are invovled in this action? |
|
Definition
activation increases both SANS and PANS resposnes.
Nicotinic Neuronal (Nn) receptors are involved in these responses. |
|
|
Term
What effect does losing your dopamine function have on your cholinergic function?
What medication could you take to correct this? |
|
Definition
If you loose your dopamine function, you accelerate your cholinergic function, thus Benztropine is a able to correct this action |
|
|
Term
List 5 drugs (or drug types) that can block M receptors? |
|
Definition
Some OTC antihistamines, antipsychotic drugs, quinidine, meperidine & tricyclic antidepressants block M receptors |
|
|
Term
An external stimulus causes innervation in a tissue (non-vascular, non-thermoregulatory), which is dually innervated by both the SANS and PANS. The patient is on a ganglion blocker. What will happen? |
|
Definition
The patient's ANS tone and reflexes (barorecptor reflex changes in HR) will be blocked becuase the ganglion blocker acts on the PANS.
Though both the PANS and SANS are stimulated, PANS always dominates unless the tissue is vascular or a thermoregulatory sweat gland.
This is a theoretical patient, since ganglion blockers have no clinical use. |
|
|
Term
What are the only parts of the body which are always regulated by the SANS |
|
Definition
Vascular tone and thermoregulatory sweat glands |
|
|
Term
What are the 6 classes of Adrenergic drugs? |
|
Definition
1.Inhibitors of NE metabolism - MAO inhibitors
2.Releasers of NE from nerve endings – eg, amphetamine
3.Blockers of NE reuptake – eg, cocaine
4.Depletors of NE storage – eg, reserpine
5. Agonist drugs acting at alpha and/or beta receptor subtypes
6. Antagonist drugs acting at alpha and/or beta receptor subtypes
|
|
|
Term
Which type of pharmacology is more complicated, Adrenergic or Cholinergic? |
|
Definition
Adreniergic Pharmacology
Because of more More complicated than Cholinergic Pharmacology because there are more
drugs & drug “targets”, more clinical uses & more adverse effects. |
|
|
Term
|
Definition
• Type: Cholinesterase Inhibitor, non-selective
• Receptor: none
• Indications: Diagnostic for myasthenia gravis & for determining treatment adequacy, Gi Ileus, Reverse neuromuscular blockage, non-depolarizing
• Contraindications: Allergic to this drug
• Drug-Drug:
• Route: IV, IM
• Side FX:, bradyarrythmia, HTN, WET picutre [sweating, abnormal gastric secretions, ↑ salivation, N/V/D (nausea, vomiting, dizziness)], dysphagia
· MOA: AChE inhibitor, so causes activation of both M & N receptors |
|
|
Term
|
Definition
Type: Cholinesterase Inhibitor
• Receptor: NA
• Indications: Glaucoma, Anticholinergic agent toxicity (atropine toxicity)
• Contraindications: asthma, CVD (cardiovascular disease), DM (diabetes mellitus), gangrene, mech obs. Of GI & Urogen tract, vagotonic state (excessive vaginal tone)
• Drug-Drug: succinylcholine
• Route: IV, IM, eye drops
• Side FX: diaphoresis (perspiring profusely), N/V/D, excessive salivation, brady arr. seizures, hypersensitivity rxns
· MOA: AChE inhibitor, so causes activation of both M & N receptors |
|
|
Term
DONEPEZIL (Aricept)
TACRINE (Cognex)
|
|
Definition
• Type: Cholinesterase Inhibitor
• Receptor: NA
• Indications: Alzheimer's, Multi-infarct dementia (Multi-infarct dementia (MID) is a form of dementia caused by a series of small strokes,
• Contraindications: Allergic to this drug
• Drug-Drug: succinylcholine, oxybutynin
• Route: Oral
• Side FX:, HTN, syncope (fainting/passing out), ↓ weight, N/V/D, bruising , cramping, ↑ creatine kinase, headache, insomnia, somnolence (drowsiness), uri. Incontinence (leakage), fatigue, AV block, GI hemorrhage
· MOA: AChE inhibitor, so causes activation of both M & N receptors high lipid solubility increases CNS access to increase ACh |
|
|
Term
|
Definition
Type: Muscarinic-1 blocker, Antagonist, non-selective
• Receptor: Muscarine-1, PANS, Cholinergic
• Indications: antispasmodic, antisecretory, antidiarrheal, antidote for organophosphates
• Contraindications: narrow angle glaucoma, reflux, esophagitis, obs. GI disease, ulcerative colitis, obs. Uropathy, unstable cardiovascular status in acute hemorrhage or thyrotoxicosis, paralytic ileus, intestinal atony, MG
• Drug-Drug:
• Route: PO, parenteral, ophthalmic
• Side FX: toxicity: dry mouth & decreased sweating – tachycardia, mydriasis(dilation of pupil) & cycloplegia (paralysis of the ciliary muscle of the eye) – hyperthermia (+ vasodilation) – urinary retention/constipation – weak pulse, hallucinations, delerium, coma. |
|
|
Term
TROPICAMIDE (Mydriacyl)
Cyclopentolate (Cyclogyl)
|
|
Definition
• Type: Muscarinic-1 Antagonist
• Receptor: Muscarinic-1, PANS, Cholinergic
• Indications: Ophthalmic examinations
• Contraindications: Glaucoma, allergy
• Drug-Drug: umeclidinium
• Route: ophthalmic
• Side FX: blurred vision, burning sensation, CNS complication, photophobia, ↑ intraocular pressure |
|
|
Term
IPRATROPIUM (Atrovert)
Tiotropium (Spiriva) |
|
Definition
• Type: Muscarinic-1 Antagonist/blocker
• Receptor: Muscarinic-1, PANS, Cholinergic
• Indications: COPD, nasal discharge, asthma management
• Contraindications: Allergies to atropine, allergy to this drug
• Drug-Drug:
• Route: inhalation, nasal spray
• Side FX: Increase ocular pressure, blurred vision, bronchodilation, increase HR, Decrease HCl acid, Decrease GI motility |
|
|
Term
|
Definition
· Type: Muscarinic Agonist (direct activator)
· Receptor: Activates all M receptors, PANS, Cholinergic
· Indications: Commonly used to increase GI or bladder motility, Post-op/Postpart to ↑ bladder muscle tone w/ nonobstructive neurogenic urinary retention. After childbirth or surgery. After anesthetics.
· Contraindications: Asthma, HTN (hypertension/high BP), compromised GI/Bladder wall, CAD (coronary artery disease), epilepsy, Hyperthyroidism, Parkinson's, peptic ulcers
· Drug-Drug:
· Route: PO, SC
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
|
Definition
· Type: Cholinergic Agonist, PANS
· Receptor: ALL cholinergic sites (muscarinic and nicotinic)
· Indications: * Used for Miosis (pupil constriction) during ophthalmic surgery, coronary angiography, Know Ach ANS effects
· Skeletal muscle-Contraction,
· Ganglion-Stimulation,
· CNS-Neurotransmissio
· Contraindications: Allergy
· Route: Eye drops
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
|
Definition
· Type: Cholinergic Agonist, PANS
· Receptor: Muscarinic (ALL)
· Indications: Increases salivary excretions; ophthalmic use for glaucoma, radiation induced xerostomia (dry mouth), ↓ intraocular pressure, Sjögren's syndrome (Sjogren syndrome is an autoimmune disorder in which the glands that produce tears and saliva are destroyed)
· Contraindications: When miosis is undesirable, pupillary block glaucoma, uncontrolled asthma
· Drug-Drug: NA
· Route: eye drops, tablets
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
|
Definition
· Type: Cholinergic Agonist, direct activator, PANS
· Receptor: Neuronal nicotinic (Nn). Some selectivity for CNS nicotinic receptors
· Indications: Smoking cessation
· Contraindications: Allergies
· Drug-Drug:
· Route: PO
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
|
Definition
· Type: Cholinergic Agonist
· Receptor: Muscarinic all (1,2,3)
· Indications: no clinical use. However, toxicity of this mushroom product is due to ibotenic acid.
· Contraindications: Allergies
· Drug-Drug:
· Route: PO
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
|
Definition
· Type: Cholinergic Agonist, direct activator, PANS
· Receptor: Nicotinic (ALL), some selectivity for CNS nicotinic receptors
· Indications: Smoking cessation
· Contraindications: Allergies
· Drug-Drug:
· Route: PO, Gum, transdermal patch
· Side FX: DUMBBELSS (diarrhea, urination, miosis (pupil constriction), bradycardia, bronchoconstriction, excitation (CNS), lacrimation, salivation, sweating). |
|
|
Term
NEOSTIGMINE (Prostigmine) |
|
Definition
· Type: AChE inhibitor, indirect activator, cholinergic, PANS
· Receptor: Muscarinic, indirect activator, indirectly causes activation of both M & N receptors
· Indications:MG (Myasthenia gravis), Use to ↑ GI & bladder motility
· Contraindications: mechanical intestinal tract obstruction, peritenitis, mech. urinary tract obstruction
· Drug-Drug: Succinylcholine
· Route: PO, parenteral
· Side FX: bradycardia, excessive salivation, muscle fasciculation (a brief, spontaneous contraction), AV block, Bradyarrhythmia, cardiac arrest, dysrhythmia, anaphylaxis, LOC, seizures |
|
|
Term
|
Definition
• Type: cholinergic blocker, muscarinic Antagonist, PANS
• Receptor: Muscarinic-2
• Indications: Motion sickness
• Contraindications:
• Drug-Drug:
• Route: PO, parenteral, opthalmic, patch
• Side FX: drowsiness, xerostomia |
|
|
Term
OXYBUTININ (Ditropan)
Tolterodine (Detrol) |
|
Definition
· Type: Muscarinic Antagonist, cholinergic, PANS
· Receptor: Muscarinic-3, selective M3 blocker
· Indications: For urinary urgency, cysitis, slow GI hypermotility
· Contraindications: Urinary retention
· Drug-Drug: Donepezil
· Route: PO
· Side FX: Angioedema |
|
|
Term
|
Definition
• Type: Muscarinic Antagonist, Cholinergic blocker, PANS
• Receptor: Muscarinic-2
• Indications: Parkinson's, Tx for OD of antipsychotic drugs (e.g. haloperidol)
• Contraindications:
• Drug-Drug:
• Route: PO, parenteral
• Side FX: |
|
|
Term
|
Definition
• Type: Nicotinic Antagonist (Depolarizing neuromuscular blocking agent). Cholinergic, PANS
• Receptor: Nicotinic
• Indications: Produce muscle relaxation before and during surgery, and to facilitate intubation of the airway.
• Contraindications: If bloodwork indicates high [K+], risk of hyperkalemia→cardiac arrest, not for 3° burn victims, children
• Drug-Drug: Do not use with Physostigmine (eserine); donepezil (aricept); Neostigmine (prostigmine)
• Route: IV, IM
• Side FX: Hyperkalemia can cause cardiac arrest, Post-op Myaliga (muscle pain) in neck, back and abdomen
|
· MOA: causes persistent depolarization of end motor plate > fasisculation > fatigue relaxation |
|
|
Term
|
Definition
Type: Adrenergic, SANS, Direct-acting Beta Agonist, non-selective
• Receptor: β1 & β2
• Indications: Rx bronchospasm/constriction, atrioventricular block/heart block, bradycardia
• Contraindications:
• Drug-Drug:
• Route: Inhalant, parenteral
• Side FX: flushing, angina, arrhyth, ↓ tone & motility of gut
· MOA: B1 cardiac stimulation; B2 bronchodilator |
|
|
Term
|
Definition
Type: Direct-acting Beta Agonist, more-selective beta agonist
• Receptor: β1>β2 & Alpha
• Indications: acute heart failure, cardiogenic shock, used for heart stimulation during heart surgery
• Contraindications:
• Drug-Drug:
• Route: parenteral
• Side FX:
· MOA: primarily stimulates B1 receptors with smaller effect on B2 and alpha receptors |
|
|
Term
|
Definition
Type: Direct-acting Beta agonist, Adrenergic, SANS
• Receptor: ALL (alpha and beta). Low dose = b1/b2. High dose = a1, b1, b2
• Indications: Rx or hemostatis (stop bleeding), adjunct to local anesthetics, Rx for acute asthma, DOC (drug of choice) for anaphylaxis, cardiac arrest, hypotension
• Contraindications:
• Drug-Drug:
• Route: aerosol, parenteral, ophthalmic
• Side FX: vasoconstriction (a1), ↑BP (a1), bronchodilation (b2)
· MOA: Released from the adrenal medulla into the bloodstream. Vasocontriction at alpha2, increased BP at alpha 1, cardiac stimulation at B1, and bronchodilation at B2 |
|
|
Term
|
Definition
Type: Direct-acting beta agonist, adrenergic, SANS
• Receptor: β2 selective
• Indications: Acute asthma
• Contraindications:
• Drug-Drug:
• Route: inhalant
• Side FX: Possible tremors
· MOA: bronchodilation of B2 |
|
|
Term
PHENYLEPHRINE (Neo-Synephrine) |
|
Definition
Type: Direct-acting Adrenoreceptor Agonist, SANS
• Receptor: α1 selective, agonist
• Indications: Rx for nasal congestion, Used to elicit mydriasis/dilation of eye (without cycloplegia =ciliary muscle paralysis which leads to loss of accomodation), Tx of shock, hypotension, maintenance of BP
• Contraindications:
• Drug-Drug:
• Route: PO, parenteral, nasal, ophthalmic
• Side FX: Angioedema, Vasoconstriction, Increased BP, Mydriasis (VIAM)
· MOA: activates A1 adrenoreceptors; smooth muscle contraction |
|
|
Term
|
Definition
Type: Indirect Agonist, NE-releaser, adrenergic
• Receptor: SANS-innervated tissues that have receptors but are not innervated (includes some skeletal muscle blood vessels), CNS
• Indications: Rx for ADHD, narcolepsy
• Contraindications:
• Drug-Drug:
• Route: PO
• Side FX: vasoconstriction, ↑ CNS stimulation, cardiac stimulation, increase in BP (VIIC)
· MOA: high lipid solubility and increases sympathetic concentrations of NE in the CNS and PNS. |
|
|
Term
|
Definition
• Type: Indirect adrenergic agonist
• Receptor: NA, NE reuptake blocker
• Indications: Used for topical vasoconstriction, local anesthetic
• Contraindications:
• Drug-Drug:
• Route: Inhalation
• Side FX: vasoconstriction, cardiac stimulation, ↑BP, ischemia & necrosis of nasal mucosa (VIICN) |
|
|
Term
|
Definition
• Type: Indirect Adrenergic Agonist, NE-releaser
• Receptor: SANS-innervated tissues that have receptors but are not innervated (includes some skeletal muscle blood vessels), CNS
• Indications: decongestant, cold remedy, vasoconstriction, bronchodilation
• Contraindications: do NOT use on children <6yo
• Drug-Drug:
• Route: PO, Parenteral
• Side FX: tachycardia, ↑ BP, urinary retention, insomnia (UTII) |
|
|
Term
|
Definition
• Type: Indirect Adrenergic Agonist, NE-releaser
• Receptor: NE releaser, binds to agonist alpha 1 receptors
• Indications: Tx for nasal congestion, cold, and allergies
• Contraindications: do NOT use on children <6yo
• Drug-Drug:
• Route: PO
• Side FX: tachycardia, ↑ BP, urinary retention, insomnia (UTII) |
|
|